Intrapulmonary penetration of antimicrobials and implications in treatment of lower respiratory tract infections

M. Cazzola (Rome, Italy)

Source: Annual Congress 2009 - Antibiotics and the lung
Session: Antibiotics and the lung
Session type: Symposium
Number: 2767
Disease area: Respiratory infections

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Cazzola (Rome, Italy). Intrapulmonary penetration of antimicrobials and implications in treatment of lower respiratory tract infections. Annual Congress 2009 - Antibiotics and the lung

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Intrapulmonary penetration of antimicrobials and implications in the treatment of lower respiratory tract infections
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=13
Year: 2004

Evaluation of antibiotics therapy for low respiratory tract infections
Source: Eur Respir J 2007; 30: Suppl. 51, 406s
Year: 2007

Antibiotic switch therapy in lower respiratory tract infections
Source: Annual Congress 2009 - Antibiotics and the lung
Year: 2009


Does antibiotic treatment of upper respiratory tract infections prevent bacterial LRTIs?
Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new?
Year: 2009



Influence of antibiotic resistance of pseudomonas aeruginosa on presenting features of community-acquired lower respiratory tract infections
Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis
Year: 2011


Role of α- and β-defensins in lower respiratory tract infections
Source: Annual Congress 2007 - Aetiology, mechanisms and treatment in lower respiratory tract infections
Year: 2007


Pharmacological interactions between antibiotics and other drugs in the treatment of lower respiratory tract infections
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=229
Year: 2004

Efficacy and safety of Cefdinir in lower respiratory tract infections
Source: Eur Respir J 2002; 20: Suppl. 38, 420s
Year: 2002

Telithromycin is as effective as comparator antibacterials in the treatment of lower respiratory tract infections
Source: Eur Respir J 2002; 20: Suppl. 38, 561s
Year: 2002

Streptococcal resistance to antibiotics in children with upper respiratory tract infections. Epidemiological aspects
Source: Annual Congress 2010 - Paediatric respiratory infection, inflammation and immunology
Year: 2010

Lower respiratory tract infections: bacteria and virus, antibiotics and steroids
Source: Annual Congress 2008 - Infection year in review
Year: 2008


Bacterial profile, antibiotic sensitivity and resistance of lower respiratory tract infections in upper Egypt
Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Year: 2011


Viral agents in children with lower respiratory tract infection
Source: Eur Respir J 2006; 28: Suppl. 50, 487s
Year: 2006

The role of atypical pathogens in the respiratory failure caused by lower respiratory tract infections
Source: Eur Respir J 2003; 22: Suppl. 45, 151s
Year: 2003

Fatal outcome in lower respiratory tract infections
Source: Eur Respir J 2004; 24: Suppl. 48, 186s
Year: 2004

Antibiotic prescribing for adults with acute cough/lower respiratory tract infection: congruence with guidelines
Source: Eur Respir J 2011; 37: 112-118
Year: 2011



Telithromycin is highly efficacious in the treatment of lower respiratory tract infections
Source: Eur Respir J 2003; 22: Suppl. 45, 151s
Year: 2003

Antibiotic resistance among patients with lower respiratory tract infections who have undergone empiric treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 787s
Year: 2006

Impact of appropriate diagnostics on the management of respiratory tract infections
Source: Value-Dx event 2021: Community-acquired respiratory tract infections: where do we stand in 2021, ECCMID 2021
Year: 2021

Bacterial agents of community-acquired lower respiratory tract infections: observational study on antimicrobial drugs susceptibility
Source: Eur Respir J 2002; 20: Suppl. 38, 421s
Year: 2002